{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:21:40Z","timestamp":1793924500216,"version":"4.8.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11030-022-10537-y","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T04:02:46Z","timestamp":1664942566000},"page":"1905-1934","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Quinoline derivatives volunteering against antimicrobial resistance: rational approaches, design strategies, structure activity relationship and mechanistic insights"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-0054","authenticated-orcid":false,"given":"Nitish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aanchal","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komalpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preet Mohinder Singh","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"10537_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/J.FM.2016.12.009","volume":"64","author":"Z Yu","year":"2017","unstructured":"Yu Z, Gunn L, Wall P, Fanning S (2017) Antimicrobial resistance and its association with tolerance to heavy metals in agriculture production. Food Microbiol 64:23\u201332. https:\/\/doi.org\/10.1016\/J.FM.2016.12.009","journal-title":"Food Microbiol"},{"key":"10537_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/PMC.S14459","volume":"6","author":"RJ Fair","year":"2014","unstructured":"Fair RJ, Tor Y (2014) Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem 6:25. https:\/\/doi.org\/10.4137\/PMC.S14459","journal-title":"Perspect Medicin Chem"},{"key":"10537_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/MDR.2012.0115","volume":"19","author":"CF Am\u00e1bile-Cuevas","year":"2013","unstructured":"Am\u00e1bile-Cuevas CF (2013) Antibiotic resistance: from darwin to lederberg to keynes. Microb Drug Resist 19:73\u201387. https:\/\/doi.org\/10.1089\/MDR.2012.0115","journal-title":"Microb Drug Resist"},{"key":"10537_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/ANNUREV-BIOPHYS-083012-130320","volume":"42","author":"E Kussell","year":"2013","unstructured":"Kussell E (2013) Evolution in microbes. Annu Rev Biophys 42:493\u2013514. https:\/\/doi.org\/10.1146\/ANNUREV-BIOPHYS-083012-130320","journal-title":"Annu Rev Biophys"},{"key":"10537_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/FPUBH.2014.00145","author":"CA Michael","year":"2014","unstructured":"Michael CA, Dominey-Howes D, Labbate M (2014) The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health 2. https:\/\/doi.org\/10.3389\/FPUBH.2014.00145","journal-title":"Front Public Health"},{"key":"10537_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/S00239-019-09914-3","volume":"88","author":"E Christaki","year":"2020","unstructured":"Christaki E, Marcou M, Tofarides A (2020) Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence. J Mol Evol 88:26\u201340. https:\/\/doi.org\/10.1007\/S00239-019-09914-3","journal-title":"J Mol Evol"},{"key":"10537_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/J.MJAFI.2014.04.011","volume":"71","author":"BAK Jindal","year":"2015","unstructured":"Jindal BAK, Pandya MK, Khan MID (2015) Antimicrobial resistance: A public health challenge. Med J Armed Forces India 71:178\u2013181. https:\/\/doi.org\/10.1016\/J.MJAFI.2014.04.011","journal-title":"Med J Armed Forces India"},{"key":"10537_CR8","unstructured":"Antibiotic\/Antimicrobial Resistance|CDC. https:\/\/www.cdc.gov\/drugresistance\/index.html. Accessed 8 Feb 2022"},{"key":"10537_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/S11427-020-1959-5","volume":"65","author":"L Luo","year":"2022","unstructured":"Luo L, Yang J, Wang C et al (2022) Natural products for infectious microbes and diseases: an overview of sources, compounds, and chemical diversities. Sci China Life Sci 65:1123\u20131145. https:\/\/doi.org\/10.1007\/S11427-020-1959-5","journal-title":"Sci China Life Sci"},{"key":"10537_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.17179\/EXCLI2018-1174","volume":"17","author":"S Mushtaq","year":"2018","unstructured":"Mushtaq S, Abbasi BH, Uzair B, Abbasi R (2018) Natural products as reservoirs of novel therapeutic agents. EXCLI J 17:420. https:\/\/doi.org\/10.17179\/EXCLI2018-1174","journal-title":"EXCLI J"},{"key":"10537_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOORG.2021.105076","author":"A Mermer","year":"2021","unstructured":"Mermer A, Keles T, Sirin Y (2021) Recent studies of nitrogen containing heterocyclic compounds as novel antiviral agents: a review. Bioorg Chem. https:\/\/doi.org\/10.1016\/J.BIOORG.2021.105076","journal-title":"Bioorg Chem"},{"key":"10537_CR12","doi-asserted-by":"publisher","DOI":"10.4155\/FMC.15.34","author":"PY Chung","year":"2015","unstructured":"Chung PY, Bian ZX, Pun HY et al (2015) Recent advances in research of natural and synthetic bioactive quinolones. Future Med Chem. https:\/\/doi.org\/10.4155\/FMC.15.34","journal-title":"Future Med Chem"},{"key":"10537_CR13","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/S13738-020-02152-1\/SCHEMES\/70","volume":"18","author":"V Basavanna","year":"2021","unstructured":"Basavanna V, Ningaiah S, Chandramouli M et al (2021) Quinolinyl-pyrazoles: synthesis and pharmacological evolution in the recent decennial. J Iran Chem Soc 18:1479\u20131522. https:\/\/doi.org\/10.1007\/S13738-020-02152-1\/SCHEMES\/70","journal-title":"J Iran Chem Soc"},{"key":"10537_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","volume":"79","author":"M Foley","year":"1998","unstructured":"Foley M, Tilley L (1998) Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 79:55\u201387. https:\/\/doi.org\/10.1016\/S0163-7258(98)00012-6","journal-title":"Pharmacol Ther"},{"key":"10537_CR15","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1016\/J.EJMECH.2009.06.031","volume":"44","author":"S Eswaran","year":"2009","unstructured":"Eswaran S, Adhikari AV, Shetty NS (2009) Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety. Eur J Med Chem 44:4637\u20134647. https:\/\/doi.org\/10.1016\/J.EJMECH.2009.06.031","journal-title":"Eur J Med Chem"},{"key":"10537_CR16","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2174\/1381612826666201006125644","volume":"27","author":"ANS da Gama","year":"2021","unstructured":"da Gama ANS, Soeiro MNC (2021) Quinoline-based compounds as key candidates to tackle drug discovery programs of microbicidal agents. Curr Pharm Des 27:1757\u20131762. https:\/\/doi.org\/10.2174\/1381612826666201006125644","journal-title":"Curr Pharm Des"},{"key":"10537_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/FPHAR.2016.00351\/BIBTEX","volume":"7","author":"JA Garcia-Salcedo","year":"2016","unstructured":"Garcia-Salcedo JA, Unciti-Broceta JD, Valverde-Pozo J, Soriano M (2016) New approaches to overcome transport related drug resistance in trypanosomatid parasites. Front Pharmacol 7:351. https:\/\/doi.org\/10.3389\/FPHAR.2016.00351\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"10537_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2148-14-142","volume":"14","author":"V Mandlik","year":"2014","unstructured":"Mandlik V, Shinde S, Singh S (2014) Molecular evolution of the enzymes involved in the sphingolipid metabolism of Leishmania: selection pressure in relation to functional divergence and conservation. BMC Evol Biol 14:142\u2013142. https:\/\/doi.org\/10.1186\/1471-2148-14-142","journal-title":"BMC Evol Biol"},{"key":"10537_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100083","volume":"1","author":"N Kumar","year":"2021","unstructured":"Kumar N, Singh A, Gulati HK et al (2021) Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study. Phytomedicine Plus 1:100083. https:\/\/doi.org\/10.1016\/j.phyplu.2021.100083","journal-title":"Phytomedicine Plus"},{"key":"10537_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/J.BMC.2020.115973","author":"BS Matada","year":"2021","unstructured":"Matada BS, Pattanashettar R, Yernale NG (2021) A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg Med Chem. https:\/\/doi.org\/10.1016\/J.BMC.2020.115973","journal-title":"Bioorg Med Chem"},{"key":"10537_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ARDP.202000232","author":"A Dorababu","year":"2021","unstructured":"Dorababu A (2021) Recent update on antibacterial and antifungal activity of quinoline scaffolds. Arch Pharm (Weinheim). https:\/\/doi.org\/10.1002\/ARDP.202000232","journal-title":"Arch Pharm (Weinheim)"},{"key":"10537_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/AID.2020.0095","volume":"36","author":"SJD Neil","year":"2020","unstructured":"Neil SJD, Campbell EM (2020) Fake science: XMRV, COVID-19, and the toxic legacy of Dr. Judy Mikovits AIDS Res Hum Retroviruses 36:545. https:\/\/doi.org\/10.1089\/AID.2020.0095","journal-title":"Judy Mikovits AIDS Res Hum Retroviruses"},{"key":"10537_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3126\/NJE.V11I1.35659","volume":"11","author":"J Robinson","year":"2021","unstructured":"Robinson J, Banerjee I, Lecl\u00e9zio A, Sathian B (2021) COVID-19 and mutations a threat level assessment. Nepal J Epidemiol 11:983. https:\/\/doi.org\/10.3126\/NJE.V11I1.35659","journal-title":"Nepal J Epidemiol"},{"key":"10537_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/J.COMPBIOMED.2021.104748","author":"S Mujwar","year":"2021","unstructured":"Mujwar S (2021) Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2. Comput Biol Med. https:\/\/doi.org\/10.1016\/J.COMPBIOMED.2021.104748","journal-title":"Comput Biol Med"},{"key":"10537_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/JFBC.14219","volume":"46","author":"S Mujwar","year":"2022","unstructured":"Mujwar S, Sun L, Fidan O (2022) In silico evaluation of food-derived carotenoids against SARS-CoV-2 drug targets: crocin is a promising dietary supplement candidate for COVID-19. J Food Biochem 46:e14219. https:\/\/doi.org\/10.1111\/JFBC.14219","journal-title":"J Food Biochem"},{"key":"10537_CR26","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1007\/S00018-016-2299-6","volume":"73","author":"R Sanju\u00e1n","year":"2016","unstructured":"Sanju\u00e1n R, Domingo-Calap P (2016) Mechanisms of viral mutation. Cell Mol Life Sci 73:4433. https:\/\/doi.org\/10.1007\/S00018-016-2299-6","journal-title":"Cell Mol Life Sci"},{"key":"10537_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/J.EJMECH.2016.03.080","volume":"117","author":"A Carta","year":"2016","unstructured":"Carta A, Briguglio I, Piras S et al (2016) A combined in silico\/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems. Eur J Med Chem 117:321\u2013334. https:\/\/doi.org\/10.1016\/J.EJMECH.2016.03.080","journal-title":"Eur J Med Chem"},{"key":"10537_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/J.EJMECH.2017.01.007","volume":"127","author":"G Barbosa-Lima","year":"2017","unstructured":"Barbosa-Lima G, da Silveira Pinto LS, Kaiser CR et al (2017) N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity. Eur J Med Chem 127:434\u2013441. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.01.007","journal-title":"Eur J Med Chem"},{"key":"10537_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/J.EJMECH.2017.10.001","volume":"141","author":"JC Lee","year":"2017","unstructured":"Lee JC, Tseng CK, Lin CK, Tseng CH (2017) Discovery of novel diarylpyrazolylquinoline derivatives as potent anti-dengue virus agents. Eur J Med Chem 141:282\u2013292. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.10.001","journal-title":"Eur J Med Chem"},{"key":"10537_CR30","doi-asserted-by":"publisher","first-page":"111925","DOI":"10.1016\/J.EJMECH.2019.111925","volume":"187","author":"F Li","year":"2020","unstructured":"Li F, Lee EM, Sun X et al (2020) Design, synthesis and discovery of andrographolide derivatives against Zika virus infection. Eur J Med Chem 187:111925. https:\/\/doi.org\/10.1016\/J.EJMECH.2019.111925","journal-title":"Eur J Med Chem"},{"key":"10537_CR31","doi-asserted-by":"publisher","first-page":"112310","DOI":"10.1016\/J.EJMECH.2020.112310","volume":"202","author":"Q Tang","year":"2020","unstructured":"Tang Q, Xu Z, Jin M et al (2020) Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: in vitro, in vivo, and combination therapy study. Eur J Med Chem 202:112310,  https:\/\/doi.org\/10.1016\/J.EJMECH.2020.112310","journal-title":"Eur J Med Chem"},{"key":"10537_CR32","doi-asserted-by":"publisher","first-page":"2013070","DOI":"10.4084\/MJHID.2013.070","volume":"5","author":"G Delogu","year":"2013","unstructured":"Delogu G, Sali M, Fadda G (2013) The Biology of Mycobacterium Tuberculosis Infection. Mediterr J Hematol Infect Dis 5:2013070. https:\/\/doi.org\/10.4084\/MJHID.2013.070","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10537_CR33","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.2174\/138161207782110408","volume":"13","author":"R Lange","year":"2007","unstructured":"Lange R, Locher H, Wyss P, Then R (2007) The targets of currently used antibacterial agents: lessons for drug discovery. Curr Pharm Des 13:3140\u20133154. https:\/\/doi.org\/10.2174\/138161207782110408","journal-title":"Curr Pharm Des"},{"key":"10537_CR34","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/J.ADDR.2005.04.003","volume":"57","author":"PA Lambert","year":"2005","unstructured":"Lambert PA (2005) Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliv Rev 57:1471\u20131485. https:\/\/doi.org\/10.1016\/J.ADDR.2005.04.003","journal-title":"Adv Drug Deliv Rev"},{"key":"10537_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1089\/ADT.2019.944","volume":"17","author":"S Mujwar","year":"2019","unstructured":"Mujwar S, Deshmukh R, Harwansh RK et al (2019) Drug repurposing approach for developing novel therapy against mupirocin-resistant staphylococcus aureus. ASSAY Drug Dev Technol 17:298\u2013309. https:\/\/doi.org\/10.1089\/ADT.2019.944","journal-title":"ASSAY Drug Dev Technol"},{"key":"10537_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/J.EJMECH.2016.12.054","volume":"127","author":"H Yang","year":"2017","unstructured":"Yang H, Wang HW, Zhu TW et al (2017) Syntheses and antibacterial activity of soluble 9-bromo substituted indolizinoquinoline-5,12-dione derivatives. Eur J Med Chem 127:166\u2013173. https:\/\/doi.org\/10.1016\/J.EJMECH.2016.12.054","journal-title":"Eur J Med Chem"},{"key":"10537_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.EJMECH.2017.04.018","volume":"135","author":"N Sun","year":"2017","unstructured":"Sun N, Du RL, Zheng YY et al (2017) Antibacterial activity of N-methylbenzofuro[3,2-b]quinoline and N-methylbenzoindolo[3,2-b]-quinoline derivatives and study of their mode of action. Eur J Med Chem 135:1\u201311. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.04.018","journal-title":"Eur J Med Chem"},{"key":"10537_CR38","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/J.EJMECH.2017.10.042","volume":"143","author":"HM Faidallah","year":"2018","unstructured":"Faidallah HM, Girgis AS, Tiwari AD et al (2018) Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates. Eur J Med Chem 143:1524\u20131534. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.10.042","journal-title":"Eur J Med Chem"},{"key":"10537_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/J.EJMECH.2018.05.021","volume":"154","author":"K Xu","year":"2018","unstructured":"Xu K, He S, Chen S et al (2018) Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents. Eur J Med Chem 154:144\u2013154. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.05.021","journal-title":"Eur J Med Chem"},{"key":"10537_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.EJMECH.2019.02.073","volume":"169","author":"CX Ma","year":"2019","unstructured":"Ma CX, Lv W, Li YX et al (2019) Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens. Eur J Med Chem 169:1\u201320. https:\/\/doi.org\/10.1016\/J.EJMECH.2019.02.073","journal-title":"Eur J Med Chem"},{"key":"10537_CR41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/J.EJMECH.2016.07.058","volume":"123","author":"S Duggirala","year":"2016","unstructured":"Duggirala S, Napoleon JV, Nankar RP et al (2016) FtsZ inhibition and redox modulation with one chemical scaffold: Potential use of dihydroquinolines against mycobacteria. Eur J Med Chem 123:557\u2013567. https:\/\/doi.org\/10.1016\/J.EJMECH.2016.07.058","journal-title":"Eur J Med Chem"},{"key":"10537_CR42","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/J.EJMECH.2017.07.004","volume":"138","author":"MA Abdelrahman","year":"2017","unstructured":"Abdelrahman MA, Salama I, Gomaa MS et al (2017) Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents. Eur J Med Chem 138:698\u2013714. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.07.004","journal-title":"Eur J Med Chem"},{"key":"10537_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/J.EJMECH.2016.09.059","volume":"125","author":"DD Subhedar","year":"2017","unstructured":"Subhedar DD, Shaikh MH, Shingate BB et al (2017) Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation. Eur J Med Chem 125:385\u2013399. https:\/\/doi.org\/10.1016\/J.EJMECH.2016.09.059","journal-title":"Eur J Med Chem"},{"key":"10537_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.EJMECH.2018.07.046","volume":"157","author":"G Kumar","year":"2018","unstructured":"Kumar G, Sathe A, Krishna VS et al (2018) Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents. Eur J Med Chem 157:1\u201313. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.07.046","journal-title":"Eur J Med Chem"},{"key":"10537_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/J.EJMECH.2018.06.005","volume":"155","author":"FS Macchi","year":"2018","unstructured":"Macchi FS, Pissinate K, Villela AD et al (2018) 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity. Eur J Med Chem 155:153\u2013164. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.06.005","journal-title":"Eur J Med Chem"},{"key":"10537_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/J.EJMECH.2018.12.043","volume":"164","author":"SK Marvadi","year":"2019","unstructured":"Marvadi SK, Krishna VS, Sriram D, Kantevari S (2019) Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis. Eur J Med Chem 164:171\u2013178. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.12.043","journal-title":"Eur J Med Chem"},{"key":"10537_CR47","doi-asserted-by":"publisher","first-page":"112179","DOI":"10.1016\/J.EJMECH.2020.112179","volume":"192","author":"AF Borsoi","year":"2020","unstructured":"Borsoi AF, Paz JD, Abbadi BL et al (2020) Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents. Eur J Med Chem 192:112179. https:\/\/doi.org\/10.1016\/J.EJMECH.2020.112179","journal-title":"Eur J Med Chem"},{"key":"10537_CR48","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2174\/138161208784041123","volume":"14","author":"W Souza","year":"2008","unstructured":"Souza W (2008) An introduction to the structural organization of parasitic protozoa. Curr Pharm Des 14:822\u2013838. https:\/\/doi.org\/10.2174\/138161208784041123","journal-title":"Curr Pharm Des"},{"key":"10537_CR49","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ejmech.2016.08.049","volume":"124","author":"M Yousuf","year":"2016","unstructured":"Yousuf M, Mukherjee D, Dey S et al (2016) Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani. Eur J Med Chem 124:468\u2013479. https:\/\/doi.org\/10.1016\/j.ejmech.2016.08.049","journal-title":"Eur J Med Chem"},{"key":"10537_CR50","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/J.EJMECH.2017.10.060","volume":"143","author":"C Zhang","year":"2018","unstructured":"Zhang C, Bourgeade Delmas S, Fern\u00e1ndez \u00c1lvarez \u00c1 et al (2018) Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold(I) complexes. Eur J Med Chem 143:1635\u20131643. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.10.060","journal-title":"Eur J Med Chem"},{"key":"10537_CR51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/J.EJMECH.2018.05.014","volume":"154","author":"A Upadhyay","year":"2018","unstructured":"Upadhyay A, Kushwaha P, Gupta S et al (2018) Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents. Eur J Med Chem 154:172\u2013181. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.05.014","journal-title":"Eur J Med Chem"},{"key":"10537_CR52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/J.EJMECH.2018.10.065","volume":"162","author":"A Tejer\u00eda","year":"2019","unstructured":"Tejer\u00eda A, P\u00e9rez-Pertejo Y, Reguera RM et al (2019) Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents. Eur J Med Chem 162:18\u201331. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.10.065","journal-title":"Eur J Med Chem"},{"key":"10537_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/J.EJMECH.2019.03.007","volume":"171","author":"M Staderini","year":"2019","unstructured":"Staderini M, Piquero M, Abeng\u00f3zar M\u00c1 et al (2019) Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold. Eur J Med Chem 171:38\u201353. https:\/\/doi.org\/10.1016\/J.EJMECH.2019.03.007","journal-title":"Eur J Med Chem"},{"key":"10537_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMECH.2019.111860","volume":"186","author":"SY Bhat","year":"2020","unstructured":"Bhat SY, Jagruthi P, Srinivas A et al (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1. Eur J Med Chem 186:111860. https:\/\/doi.org\/10.1016\/J.EJMECH.2019.111860","journal-title":"Eur J Med Chem"},{"key":"10537_CR55","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/J.EJMECH.2017.10.051","volume":"148","author":"EA Valverde","year":"2018","unstructured":"Valverde EA, Romero AH, Acosta ME et al (2018) Synthesis, \u03b2-hematin inhibition studies and antimalarial evaluation of new dehydroxy isoquine derivatives against Plasmodium berghei: A promising antimalarial agent. Eur J Med Chem 148:498\u2013506. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.10.051","journal-title":"Eur J Med Chem"},{"key":"10537_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/J.EJMECH.2016.09.044","volume":"125","author":"A Singh","year":"2017","unstructured":"Singh A, Gut J, Rosenthal PJ, Kumar V (2017) 4-Aminoquinoline-ferrocenyl-chalcone conjugates: synthesis and anti-plasmodial evaluation. Eur J Med Chem 125:269\u2013277. https:\/\/doi.org\/10.1016\/J.EJMECH.2016.09.044","journal-title":"Eur J Med Chem"},{"key":"10537_CR57","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/J.EJMECH.2017.03.007","volume":"131","author":"R Kholiya","year":"2017","unstructured":"Kholiya R, Khan SI, Bahuguna A et al (2017) N-Piperonyl substitution on aminoquinoline-pyrimidine hybrids: effect on the antiplasmodial potency. Eur J Med Chem 131:126\u2013140. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.03.007","journal-title":"Eur J Med Chem"},{"key":"10537_CR58","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/J.EJMECH.2017.07.041","volume":"138","author":"S Kumar","year":"2017","unstructured":"Kumar S, Saini A, Gut J et al (2017) 4-Aminoquinoline-chalcone\/-N-acetylpyrazoline conjugates: synthesis and antiplasmodial evaluation. Eur J Med Chem 138:993\u20131001. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.07.041","journal-title":"Eur J Med Chem"},{"key":"10537_CR59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/J.EJMECH.2018.02.048","volume":"149","author":"R Capela","year":"2018","unstructured":"Capela R, Magalh\u00e3es J, Miranda D et al (2018) Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability. Eur J Med Chem 149:69\u201378. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.02.048","journal-title":"Eur J Med Chem"},{"key":"10537_CR60","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/J.EJMECH.2018.06.025","volume":"155","author":"UK Sharma","year":"2018","unstructured":"Sharma UK, Mohanakrishnan D, Sharma N et al (2018) Facile synthesis of vanillin-based novel bischalcones identifies one that induces apoptosis and displays synergy with Artemisinin in killing chloroquine resistant Plasmodium falciparum. Eur J Med Chem 155:623\u2013638. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.06.025","journal-title":"Eur J Med Chem"},{"key":"10537_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/J.EJMECH.2018.08.063","volume":"158","author":"L Bonilla-Ramirez","year":"2018","unstructured":"Bonilla-Ramirez L, Rios A, Quiliano M et al (2018) Novel antimalarial chloroquine-and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies. Eur J Med Chem 158:68\u201381. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.08.063","journal-title":"Eur J Med Chem"},{"key":"10537_CR62","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/J.EJMECH.2018.01.062","volume":"146","author":"J Levati\u0107","year":"2018","unstructured":"Levati\u0107 J, Pavi\u0107 K, Perkovi\u0107 I et al (2018) Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity. Eur J Med Chem 146:651\u2013667. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.01.062","journal-title":"Eur J Med Chem"},{"key":"10537_CR63","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/J.EJMECH.2018.11.021","volume":"162","author":"SS Maurya","year":"2019","unstructured":"Maurya SS, Bahuguna A, Khan SI et al (2019) N-Substituted aminoquinoline-pyrimidine hybrids: synthesis, in vitro antimalarial activity evaluation and docking studies. Eur J Med Chem 162:277\u2013289. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.11.021","journal-title":"Eur J Med Chem"},{"key":"10537_CR64","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/J.EJMECH.2015.11.027","volume":"108","author":"Q Ji","year":"2016","unstructured":"Ji Q, Ge Z, Ge Z et al (2016) Synthesis and biological evaluation of novel phosphoramidate derivatives of coumarin as chitin synthase inhibitors and antifungal agents. Eur J Med Chem 108:166\u2013176. https:\/\/doi.org\/10.1016\/J.EJMECH.2015.11.027","journal-title":"Eur J Med Chem"},{"key":"10537_CR65","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/J.EJMECH.2016.02.016","volume":"112","author":"SC Karad","year":"2016","unstructured":"Karad SC, Purohit VB, Thakor P et al (2016) Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities. Eur J Med Chem 112:270\u2013279. https:\/\/doi.org\/10.1016\/J.EJMECH.2016.02.016","journal-title":"Eur J Med Chem"},{"key":"10537_CR66","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/J.EJMECH.2017.10.025","volume":"141","author":"R Duroux","year":"2017","unstructured":"Duroux R, Rami M, Landagaray E et al (2017) Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT1\/MT2) and serotoninergic (5-HT2C) dual ligands. Eur J Med Chem 141:552\u2013566. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.10.025","journal-title":"Eur J Med Chem"},{"key":"10537_CR67","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/J.EJMECH.2017.10.046","volume":"143","author":"MF el Shehry","year":"2018","unstructured":"el Shehry MF, Ghorab MM, Abbas SY et al (2018) Quinoline derivatives bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents. Eur J Med Chem 143:1463\u20131473. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.10.046","journal-title":"Eur J Med Chem"},{"key":"10537_CR68","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/J.EJMECH.2017.11.083","volume":"143","author":"K Pavi\u0107","year":"2018","unstructured":"Pavi\u0107 K, Perkovi\u0107 I, Posp\u00ed\u0161ilov\u00e1 \u0160 et al (2018) Primaquine hybrids as promising antimycobacterial and antimalarial agents. Eur J Med Chem 143:769\u2013779. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.11.083","journal-title":"Eur J Med Chem"},{"key":"10537_CR69","doi-asserted-by":"publisher","first-page":"112324","DOI":"10.1016\/J.EJMECH.2020.112324","volume":"199","author":"A Okumu","year":"2020","unstructured":"Okumu A, Lu Y, Dellos-Nolan S et al (2020) Novel bacterial topoisomerase inhibitors derived from isomannide. Eur J Med Chem 199:112324. https:\/\/doi.org\/10.1016\/J.EJMECH.2020.112324","journal-title":"Eur J Med Chem"},{"key":"10537_CR70","doi-asserted-by":"publisher","first-page":"112513","DOI":"10.1016\/J.EJMECH.2020.112513","volume":"202","author":"AAM Mohammed","year":"2020","unstructured":"Mohammed AAM, Suaifan GARY, Shehadeh MB, Okechukwu PN (2020) Design, synthesis and antimicrobial evaluation of novel glycosylated-fluoroquinolones derivatives. Eur J Med Chem 202:112513. https:\/\/doi.org\/10.1016\/J.EJMECH.2020.112513","journal-title":"Eur J Med Chem"},{"key":"10537_CR71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1166\/JMIHI.2015.1358","volume":"5","author":"S Mujwar","year":"2015","unstructured":"Mujwar S, Pardasani KR (2015) Prediction of Riboswitch as a Potential Drug Target for Infectious Diseases: An Insilico Case Study of Anthrax. J Med Imaging Health Inform 5:7\u201316. https:\/\/doi.org\/10.1166\/JMIHI.2015.1358","journal-title":"J Med Imaging Health Inform"},{"key":"10537_CR72","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.13005\/BBRA\/1889","volume":"12","author":"P Pradhan","year":"2015","unstructured":"Pradhan P, Soni NK, Chaudhary L et al (2015) In-silico prediction of riboswitches and design of their potent inhibitors for H1N1, H2N2 and H3N2 strains of influenza virus. Biosci Biotechnol Res Asia 12:2173\u20132186. https:\/\/doi.org\/10.13005\/BBRA\/1889","journal-title":"Biosci Biotechnol Res Asia"},{"key":"10537_CR73","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1504\/IJCBDD.2016.078278","volume":"9","author":"A Kaur","year":"2016","unstructured":"Kaur A, Mujwar S, Adlakha N (2016) In-silico analysis of riboswitch of Nocardia farcinica for design of its inhibitors and pharmacophores. Int J Comput Biol Drug Des 9:261\u2013276. https:\/\/doi.org\/10.1504\/IJCBDD.2016.078278","journal-title":"Int J Comput Biol Drug Des"},{"key":"10537_CR74","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1504\/IJCBDD.2015.073671","volume":"8","author":"S Mujwar","year":"2015","unstructured":"Mujwar S, Pardasani KR (2015) Prediction of riboswitch as a potential drug target and design of its optimal inhibitors for mycobacterium tuberculosis. Int J Comput Biol Drug Des 8:326\u2013347. https:\/\/doi.org\/10.1504\/IJCBDD.2015.073671","journal-title":"Int J Comput Biol Drug Des"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10537-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-022-10537-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10537-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:39:47Z","timestamp":1744191587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-022-10537-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10537"],"URL":"https:\/\/doi.org\/10.1007\/s11030-022-10537-y","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No interest of conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}